Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premedication and preparation package for children with autism spectrum disorder undergoing surgery
ACTRN12616001078448Phase 3Not yet recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Autism Spectrum Disorder (ASD) comparing Clonidine plus low-dose midazolam with Placebo plus standard-dose midazolam (2 arms). Primary endpoint: Quality of induction of anaesthesia. Planned start Sep 2016; status: not yet recruiting.
02
Drugs
clonidinemidazolam
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12616001078448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001078448.